- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02341742
Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease (PHYSICOSMICI)
January 29, 2018 updated by: University Hospital, Lille
Relationship Between Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease
This study is an observational study.
The purpose of this study is to assess the relationship between bone health and daily physical activity in children and adolescents with inflammatory bowel disease (IBD).
Reduced bone mineral density is a common complication in pediatric IBD.
Physical activity is an important determinant of health throughout the whole lifespan.
Engaging in regular moderate-to-vigorous physical activity has important health benefits.
Based on available evidence, the investigators hypothesize that daily moderate-to-vigorous physical activity could improve bone health (ie bone mineral density) in children and adolescents with IBD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To carry out this study, 120 patients (age ≥6 and <18 years at the screening visit) will be enrolled in this observational study.
After obtaining the informed consent from the parents and the patient, the followings will be performed: clinical examination by a physician, dual-energy X-ray absorptiometry to assess bone density mineral and body composition, collection of a blood sample to assess the inflammatory status of the IBD patient.
The patient will be asked also to fill in a questionnaire in order to assess quality of life.
He will wear an accelerometer during 7 consecutive days for assessing daily physical activity in free living conditions.
The main objective is to assess the relationship between daily physical activity and bone health in children and adolescents with IBD.
The secondary objectives are to assess the relationship between daily physical activity and: 1) body composition and 2): quality of life in IBD children and adolescents.
To our knowledge, this study is the first to assess the relationship between bone health and daily physical activity in IBD children and adolescents.
Study Type
Observational
Enrollment (Actual)
84
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France
- Chu Amiens-Picardie - Site Sud
-
Arras, France
- Centre Hospitalier
-
Béthune, France
- Centre Hospitalier
-
Lens, France
- Centre Hospitalier
-
Lille, France
- Centre Hospitalier St Vincent
-
Roubaix, France
- Centre Hospitalier
-
-
Nord
-
Lille, Nord, France, 59037
- Clinical Investigation Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children and Adolescents With Inflammatory Bowel Disease: Crohn´s disease and Ulcerative colitis
Description
Inclusion Criteria:
- Boys or girls aged between 6 and 18 years old
- Chronic, acute or intermittent diseas (other than IBD) that can lead to decreased physical activity (example: fracture, paralysis, blindness ...
- Patient with IBD diagnosed since at least 6 months
- Written informed consent obtained by the the parents and the patient
- To have a health insurance
Exclusion Criteria:
- Acute intercurrent events (less than 15 days) at the inclusion day leading to decreased physical activity according to the investigator judgment (fracture(s), recent arthritis, perineal lesions, severe skin lesions)
- Patient refusing to participate to the study
- One of the child's parents refusing to participate to the study
- Lack of adherence foreseeable
- Participation to another study
- Pregnant girls
- Under a justice protect measure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients
follow up of patients (children and adolescent) with inflammatory bowel disease in looking for the relationship between the bone mineral density and physical activity.
|
biological,clinical, X-ray, DXA, accelerometry assessment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dual energy-ray absorptiometry (bone mineral density)
Time Frame: At 3 weeks
|
We assess the bone mineral density with the Dual energy-ray absorptiometry method at the visit 2 corresponding at 3 weeks after the visit 1
|
At 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dual energy-ray absorptiometry (Fat Mass)
Time Frame: At 3 weeks
|
We assess the Fat Mass with the Dual energy-ray absorptiometry method at the visit 2 corresponding at 3 weeks after the visit 1
|
At 3 weeks
|
Dual energy-ray absorptiometry (Fat Free Mass)
Time Frame: At 3 weeks
|
We assess the Fat Free Mass with the Dual energy-ray absorptiometry method at the visit 2 corresponding at 3 weeks after the visit 1
|
At 3 weeks
|
Accelerometry ( Physical Activity)
Time Frame: At 3 weeks
|
We assess the Physical Activity with the accelerometry method during 7 consecutive days
|
At 3 weeks
|
IMPACT III Questionnaire (quality of life)
Time Frame: At 3 weeks
|
We assess the quality of life throughout the IMPACT III questionnaire at the visit 2 corresponding at 3 weeks after the visit 1
|
At 3 weeks
|
PedsQL Questionnaire (quality of life)
Time Frame: At 3 weeks
|
We assess the quality of life throughout the PedsQL questionnaire at the visit 2 corresponding at 3 weeks after the visit 1
|
At 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dominique TURCK, MD, PhD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2014
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
January 7, 2015
First Submitted That Met QC Criteria
January 16, 2015
First Posted (Estimate)
January 19, 2015
Study Record Updates
Last Update Posted (Actual)
January 30, 2018
Last Update Submitted That Met QC Criteria
January 29, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013_69
- 2014-A00685-42 (Other Identifier: ID-RCB number, ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Disease
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Wisconsin, MadisonTerminatedInflammatory Bowel Disease (IBD)United States
-
Cedars-Sinai Medical CenterUnknownPediatric Inflammatory Bowel Disease
-
Hull University Teaching Hospitals NHS TrustWellcome/EPSRC Centre for Interventional and Surgical Sciences, University...RecruitingInflammatory Bowel Disease 1United Kingdom
-
Assiut UniversityNot yet recruitingIBD-Inflammatory Bowel Disease
-
University of Wisconsin, MadisonCompletedInflammatory Bowel Disease (IBD)United States
-
Kyungpook National University HospitalDaegu Catholic University Medical Center; Yeungnam University Hospital; DongGuk...RecruitingIdiopathic Chronic Inflammatory Bowel DiseaseKorea, Republic of
-
Assiut UniversityUnknownHepatobilliary Manifestations in Inflammatory Bowel Disease Patients
Clinical Trials on multiple examinations
-
Centre Hospitalier St AnneUnknownPatients With Cognitive DisturbancesFrance
-
University Hospital, ToulouseNot yet recruitingAttention Deficit Disorder With Hyperactivity
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
The First Affiliated Hospital of Zhengzhou UniversityCompleted
-
Burapha UniversityCompletedAtrial Fibrillation | Type 2 DiabetesThailand
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Oslo University HospitalRecruitingRetinitis Pigmentosa | Retinitis Pigmentosa 11Norway
-
Cuiaba UniversityCompletedObesity | Diabetes | FastingBrazil
-
Peking University Third HospitalNot yet recruitingRotator Cuff Injury
-
Singapore General HospitalActive, not recruitingVascular Diseases | Varicose Veins | Venous InsufficiencySingapore